SCRI-CAR19v3 / Seattle Children's Hospital - LARVOL DELTA

REACT-01: Reversing Autoimmunity Through Cell Therapy (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: Seattle Children's Hospital | Not yet recruiting ➔ Recruiting | Trial completion date: Jul 2041 ➔ Oct 2041 | Initiation date: Jul 2024 ➔ Oct 2024 | Trial primary completion date: Jul 2028 ➔ Oct 2028

Enrollment open • Trial completion date • Trial initiation date • Trial primary completion date • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus